title: Ovarian cancer risk associated with inherited inflammation-related variants.
abstract: The importance of inflammation pathways to the development of many human cancers prompted us to examine the associations between single-nucleotide polymorphisms (SNP) in inflammation-related genes and risk of ovarian cancer. In a multisite case-control study, we genotyped SNPs in a large panel of inflammatory genes in 930 epithelial ovarian cancer cases and 1,037 controls using a custom array and analyzed by logistic regression. SNPs with P < 0.10 were evaluated among 3,143 cases and 2,102 controls from the Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI) post-GWAS collaboration. Combined analysis revealed association with SNPs rs17561 and rs4848300 in the interleukin gene IL1A which varied by histologic subtype (P(heterogeneity) = 0.03). For example, IL1A rs17561, which correlates with numerous inflammatory phenotypes, was associated with decreased risk of clear cell, mucinous, and endometrioid subtype, but not with the most common serous subtype. Genotype at rs1864414 in the arachidonate 5-lipoxygenase ALOX5 was also associated with decreased risk. Thus, inherited variation in IL1A and ALOX5 seems to affect ovarian cancer risk which, for IL1A, is limited to rarer subtypes. Given the importance of inflammation in tumorigenesis and growing evidence of subtype-specific features in ovarian cancer, functional investigations will be important to help clarify the importance of inherited variation related to inflammation in ovarian carcinogenesis.
authors.affiliation: Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
authors.forename: Kristin L
authors.initials: KL
authors.lastname: White
authors.forename: Joellen M
authors.initials: JM
authors.lastname: Schildkraut
authors.forename: Rachel T
authors.initials: RT
authors.lastname: Palmieri
authors.forename: Edwin S
authors.initials: ES
authors.lastname: Iversen
authors.forename: Andrew
authors.initials: A
authors.lastname: Berchuck
authors.forename: Robert A
authors.initials: RA
authors.lastname: Vierkant
authors.forename: David N
authors.initials: DN
authors.lastname: Rider
authors.forename: Bridget
authors.initials: B
authors.lastname: Charbonneau
authors.forename: Mine S
authors.initials: MS
authors.lastname: Cicek
authors.forename: Rebecca
authors.initials: R
authors.lastname: Sutphen
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Birrer
authors.forename: Paul P D
authors.initials: PP
authors.lastname: Pharoah
authors.forename: Honglin
authors.initials: H
authors.lastname: Song
authors.forename: Jonathan
authors.initials: J
authors.lastname: Tyrer
authors.forename: Simon A
authors.initials: SA
authors.lastname: Gayther
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Ramus
authors.forename: Nicolas
authors.initials: N
authors.lastname: Wentzensen
authors.forename: Hannah P
authors.initials: HP
authors.lastname: Yang
authors.forename: Montserrat
authors.initials: M
authors.lastname: Garcia-Closas
authors.forename: Catherine M
authors.initials: CM
authors.lastname: Phelan
authors.forename: Julie M
authors.initials: JM
authors.lastname: Cunningham
authors.forename: Brooke L
authors.initials: BL
authors.lastname: Fridley
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Sellers
authors.forename: Ellen L
authors.initials: EL
authors.lastname: Goode
mesh_terms: D058927:5-Lipoxygenase-Activating Proteins / Q000235:genetics*; D000077216:Carcinoma, Ovarian Epithelial; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D007249:Inflammation / Q000235:genetics; D053582:Interleukin-1alpha / Q000235:genetics*; D009375:Neoplasms, Glandular and Epithelial / Q000235:genetics* / Q000473:pathology; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000473:pathology; D020641:Polymorphism, Single Nucleotide; D012306:Risk
chemical_list: D058927:5-Lipoxygenase-Activating Proteins; C548592:ALOX5AP protein, human; C508584:IL1A protein, human; D053582:Interleukin-1alpha